Scientific Programme

To view this page in Spanish, click here
To view this page in Brazilian Portuguese, click here

Thursday 19 April 2018

0900-0915Official Opening
Juan Sierra Madero, Mexico City, Mexico and Mauro Schechter, Rio de Janeiro, Brazil

0915-1045Role of Integrase Inhibitors in LATAM: Are We Ready for First-Line?
Co-chairs: Juan Sierra Madero and Mauro Schechter
0915-0930Current role of integrase inhibitors in Latin American guidelines
Ernesto Martinez Buitrago, Santiago de Cali, Colombia
0930-0955Observational studies with integrase inhibitors and experience with
first-line use in Brazil

Ricardo Diaz, São Paulo, Brazil
0955-1015Transmitted HIV drug resistance in Latin American countries. A reason
to screen or to avoid NNRTI in first line?

Santiago Avila-Rios, Mexico City, Mexico
1015-1030Discussion

1045-1100Coffee

1100-1200Keynote Lectures
1100-1130What is needed to end HIV/AIDS?
Demetre Daskalakis, New York, USA
1130-1200What we mean in our region by ending AIDS?
Jean Pape, Port-au-Prince, Haiti

1200-1315TB Diagnosis and Treatment: An Update for the Region
1200-1220New methods for TB diagnosis
Rafael Lopez, Washington DC, USA
1220-1240Treatment for disease resistant TB
Anton Pozniak, Chelsea and Westminster Hospital, London, UK
1240-1255First-hand experience from Brazil: lessons learned
Ezio Távora, Rio de Janeiro, Brazil
1240-1255Oral papers
1255-1315Discussion

1315-1430Scientific Posters and Lunch

1430-1530Keynote Lectures
1430-1500The microbiome in HIV infection
Sandra Pinto-Cardoso, Mexico City, Mexico
1500-1530Early treatment of HIV in infants
Karin A Nielsen, Los Angeles, USA

1530-1645Women with HIV in Latin America
1530-1555Diagnosis and treatment of HIV positive women with comorbidities
Monica Mantilla, Bogota, Colombia
1555-1615ARV safety in pregnancy
1615-1645Oral papers

1645-1700Coffee

1700-1830Industry Symposium

1830-1915Welcome Reception and Posters

Friday 20 April 2018

0900-1030Industry Symposium

1030-1045Coffee

1045-1115Keynote Lecture
1045-1115Update on PEP and on its role in the era of PrEP?
Dawn Smith, Atlanta, USA

1115-1215HIV and Vulnerable Populations
1115-1135Transgenders
Benjamim Braga, Rio de Janeiro, Brazil
1135-1155Adolescents
Daisy Machado, São Paulo, Brazil
1155-1215Oral Paper

1215-1330State of the ART
Chair: Roy Gulick, New York, USA
1215-1230Dual therapy
Pedro Cahn, Buenos Aires, Argentina
1230-1300HIV and new drugs
Daniel Kuritzkes, Boston, USA
1300-1330Discussion

1330-1430Lunch

1430-1600Hepatitis C. New Drugs and What Can We Learn from HIV?
1430-1450New HCV drugs in the region
Mark Nelson, London, UK
1450-1505Home/self-testing: how in HIV? When and to whom?
Omar Sued, Buenos Aires, Argentina
1505-1520Translating lessons from HIV to hepatitis C
Jorge Santana, San Juan, Puerto Rico
1520-1600Discussion

1600-1615Coffee

1615-1745Observational Data to Address Epidemiological Issues in Latin America and
the Caribbean. What Have We Learned?

1745-1800Coffee

1800-1900Industry Symposium

1900-1945Reception and Posters

Saturday 21 April 2018

0900-0930CROI 2018: What’s New?
Luis Soto-Ramirez, Mexico City, Mexico

0930-1000Challenging Cases in HIV:Interactive Case Study Session
In collaboration with International Antiviral Society-USA
(IAS-USA)
Moderator: Roy Gulick
0930-0950What to start?
0950-1010Treatment Failure
0930-0950PrEP

1030-1045Coffee

1045-1215Perspectives in Public Health “Old STIs – New Challenges”
In collaboration with the Pan American Health Organization (PAHO)
Chair: Massimo Ghidinelli, Washington DC, USA
Facilitator: Maeve de Mello, Washington DC, USA
1045-1105Historic perspectives and public health significance of syphilis and other
STIs(gonococcal infection and non-gonococcal urethritis)

Massimo Ghidinelli and Maeve de Mello
1105-1120Syphilis amongst key populations
Mary Kamb, Atlanta, USA
1120-1135Innovation: Community based STI clinic and interventions in San Francisco
Jeffrey Klausner, San Francisco, USA
1135-1150 Outcomes of HIV and syphilis infection amoung pregnant women in Haiti
Marie M. Deschamps, Port-au-Prince, Haiti

1150-1215Discussion

1215-1230Coffee

1230-1415Update on PrEP
Session in collaboration with the International AIDS Society (IAS)
1230-1250PrEP: an overview
Kenneth Mayer, Boston, USA
1250-1310HIV prevention: PrEP situation in Latin American countries
Giovanni Ravasi, Washington DC, USA
1310-1330PrEP implementation in STD clinics
Hugo Lopez-Gatell, Mexico City, Mexico
1330-1415Discussion/debate

1415-1430Official Close

1430-1515Lunch